Literature DB >> 22059698

Anterior and posterior reconstruction technique and its impact on early return of continence after robot-assisted radical prostatectomy.

Fatih Atug1, Ali Riza Kural, Ilter Tufek, Sudesh Srivastav, Haluk Akpinar.   

Abstract

BACKGROUND AND
PURPOSE: Urinary incontinence is a significant cause of morbidity after robot-assisted radical prostatectomy (RARP). Several techniques have been developed to improve continence rates. In this study, we compared the continence rates of patients who underwent RARP with total reconstruction and without reconstruction. PATIENTS AND METHODS: Between March 2005 and September 2009, 245 patients underwent RARP at our institution. The initial 120 patients (control group) underwent standard RARP without reconstruction and the last 125 patients (reconstruction group) underwent a total reconstruction technique, which included an anterior and posterior reconstruction. Patients were followed for 1, 4, 12, 24, 36, and 52 weeks after the operation. Continence was defined with strict criteria-no usage of pads and no leakage of urine.
RESULTS: In the reconstruction group, the continence rates at, 1, 4, 12, 24, 36, and 52 weeks postoperatively were 71%, 72%, 80%, 84%, 86%, and 91%, respectively; in the control group, the continence rates were 23%, 49%, 76%, 80%, 85%, and 88%, respectively.
CONCLUSION: The overall continence rates were similar in both groups at 52 weeks of follow-up. Patients in the total reconstruction group, however, had higher early continence rates compared with patients in the control group. The total reconstruction procedure is an efficient way to achieve an early return to continence.

Entities:  

Mesh:

Year:  2012        PMID: 22059698     DOI: 10.1089/end.2010.0654

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

1.  [Prevention of postprostatectomy incontinence: etiology and risk factors].

Authors:  R Mager; M Kurosch; T Hüsch; M Reiter; I Tsaur; A Haferkamp
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

2.  Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients.

Authors:  A I Tasci; I Tufek; E Gumus; A E Canda; V Tugcu; F Atug; U Boylu; Z Akbulut; S Sahin; A Simsek; A R Kural
Journal:  World J Urol       Date:  2014-09-13       Impact factor: 4.226

Review 3.  Surgical Techniques to Optimize Early Urinary Continence Recovery Post Robot Assisted Radical Prostatectomy for Prostate Cancer.

Authors:  Ashwin N Sridhar; Mohammed Abozaid; Prabhakar Rajan; Prasanna Sooriakumaran; Greg Shaw; Senthil Nathan; John D Kelly; Tim P Briggs
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

4.  Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?

Authors:  Diwei Lin; Michael O'Callaghan; Rowan David; Andrew Fuller; Richard Wells; Peter Sutherland; Darren Foreman
Journal:  BMC Urol       Date:  2020-01-31       Impact factor: 2.264

5.  Early continence recovery after preservation of maximal urethral length until the level of verumontanum during radical prostatectomy: primary oncological and functional outcomes after 1 year of follow-up.

Authors:  Stavros Sfoungaristos; Stavros Kontogiannis; Petros Perimenis
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

6.  Urinary Continence Outcomes after Puboprostatic Ligament Preserving Open Retropubic Radical Prostatectomy at a Sub-Saharan Hospital.

Authors:  S Kaggwa; M Galukande
Journal:  Int Sch Res Notices       Date:  2014-12-18

7.  The efficacy and feasibility of total reconstruction versus nontotal reconstruction of the pelvic floor on short-term and long-term urinary continence rates after radical prostatectomy: a meta-analysis.

Authors:  Yu-Peng Wu; Ning Xu; Shi-Tao Wang; Shao-Hao Chen; Yun-Zhi Lin; Xiao-Dong Li; Qing-Shui Zheng; Yong Wei; Xue-Yi Xue
Journal:  World J Surg Oncol       Date:  2017-12-20       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.